logo

ANRO

Alto Neuroscience·NYSE
--
--(--)
--
--(--)
4.64 / 10
Netural

ANRO's fundamentals score 4.6/10, indicating a fair but not outstanding position. Key positives include a high revenue growth rate (92.79% YoY in operating revenue) and a healthy interest-coverage ratio (15.5), which support the company's ability to service debt. However, factors like Asset-MV (-0.506) and Net profit / Total profit (%) (100%) are neutral or sub-optimal, suggesting room for improvement in asset utilization and profit consistency. Overall, the balance of strengths and weaknesses leads to a neutral fundamental rating.

Fundamental(4.64)SentimentTechnical

Analysis Checks(9/10)

Revenue-MV
Value-0.26
Score3/3
Weight22.79%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value78.62
Score3/3
Weight1.47%
1M Return0.88%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.90%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight18.29%
1M Return8.99%
PB-ROE
Value-0.31
Score3/3
Weight26.32%
1M Return13.65%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.97%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight0.17%
1M Return0.10%
Asset-MV
Value-0.51
Score1/3
Weight18.83%
1M Return8.68%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.56%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight17.56%
1M Return8.80%
Is ANRO fundamentally strong?
  • ANRO scores 4.64/10 on fundamentals and holds a Fair valuation at present. Backed by its -35.78% ROE, 0.00% net margin, -7.59 P/E ratio, 4.24 P/B ratio, and 53.25% earnings growth, these metrics solidify its Netural investment rating.